Skip to Main Content
Back to News

Insider Sale: Chief Financial Officer of $RVMD Sells 4,762 Shares

Automated

Jack Anders, the Chief Financial Officer of $RVMD, sold 4,762 shares of the company on 09-02-2025 for an estimated $190,560. We received data on the trade from a recent SEC filing. This was a sale of approximately 4.0% of their shares of this class of stock. Following this trade, they now own 113,314 shares of this class of $RVMD stock.

$RVMD Insider Trading Activity

RVMD Insider Trades

$RVMD insiders have traded $RVMD stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.

Here’s a breakdown of recent trading of $RVMD stock by insiders over the last 6 months:

  • MARK A GOLDSMITH (See Remarks) has made 0 purchases and 2 sales selling 25,234 shares for an estimated $995,800.
  • JACK ANDERS (Chief Financial Officer) has made 0 purchases and 4 sales selling 14,034 shares for an estimated $560,194.
  • STEPHEN MICHAEL KELSEY (See Remarks) has made 0 purchases and 2 sales selling 7,583 shares for an estimated $299,429.
  • JEFF CISLINI (General Counsel) has made 0 purchases and 4 sales selling 7,289 shares for an estimated $286,465.
  • MARGARET A HORN (Chief Operating Officer) has made 0 purchases and 2 sales selling 6,568 shares for an estimated $259,188.
  • LIN WEI (Chief Medical Officer) sold 2,173 shares for an estimated $86,550

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$RVMD Hedge Fund Activity

We have seen 161 institutional investors add shares of $RVMD stock to their portfolio, and 162 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$RVMD Analyst Ratings

Wall Street analysts have issued reports on $RVMD in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Piper Sandler issued a "Overweight" rating on 08/19/2025
  • Wells Fargo issued a "Overweight" rating on 08/15/2025
  • Needham issued a "Buy" rating on 08/07/2025
  • Goldman Sachs issued a "Buy" rating on 07/15/2025
  • Guggenheim issued a "Buy" rating on 06/25/2025
  • HC Wainwright & Co. issued a "Buy" rating on 05/14/2025
  • Oppenheimer issued a "Outperform" rating on 05/08/2025

To track analyst ratings and price targets for $RVMD, check out Quiver Quantitative's $RVMD forecast page.

$RVMD Price Targets

Multiple analysts have issued price targets for $RVMD recently. We have seen 10 analysts offer price targets for $RVMD in the last 6 months, with a median target of $69.5.

Here are some recent targets:

  • Kelsey Goodwin from Piper Sandler set a target price of $75.0 on 08/19/2025
  • An analyst from LifeSci Capital set a target price of $80.0 on 08/18/2025
  • An analyst from Wells Fargo set a target price of $67.0 on 08/15/2025
  • Ami Fadia from Needham set a target price of $56.0 on 08/07/2025
  • Andrea Newkirk from Goldman Sachs set a target price of $65.0 on 07/15/2025
  • Michael Schmidt from Guggenheim set a target price of $80.0 on 06/25/2025
  • Robert Burns from HC Wainwright & Co. set a target price of $72.0 on 05/14/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles